Sethi Sunil, Das Anindita, Kakkar Neerja, Banga S S, Prabhakar S, Sharma Meera
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandiagrh, India.
Indian J Med Res. 2005 Sep;122(3):249-53.
The clinical diagnosis of neurosyphilis is very rarely encountered today in the developed world although syphilis remains a significant health problem in few areas of the industrialized countries and in most of the third world nations. This apparent decline may be due to increase in number of asymptomatic neurosyphilis and cases presenting as subtle, illdefined syndromes rather than classic presentation of tabes dorsalis and general paresis in the post penicillin era. This retrospective study was carried out to report the neurosyphilis cases diagnosed at a tertiary care hospital in North India, and to analyse the laboratory and clinical parameters of these cases.
Suspected cases of neurosyphilis presenting at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh over a period of 13 yr (January 1990 to December 2002) were identified. Diagnosis of neurosyphilis was based on clinical presentation, prior history of syphilis, routine CSF biochemistry (protein and leukocytes) and serological evidence [serum and CSF venereal disease research laboratory (VDRL) and Treponema pallidum particle agglutination (TPPA) tests].
A total of 25 cases of neurosyphilis were identified, 18 (72%) with reactive CSF-VDRL, 22 (88%) with elevated CSF protein and 24 (96%) with CSF mononuclear leukocytosis. Serum VDRL was reactive in all 25 cases. Three patients were asymptomatic (2 primary syphilis; 1 early latent stage), 8 had secondary and 14 had tertiary syphilis. Two of the neurosyphilis cases were also seropositive for HIV. Radiology was abnormal in 7 (28%) patients.
Neurosyphilis still remains a problem in a country like India and a high index of suspicion and clinical expertise are required for appropriate diagnosis and proper management especially in the era of AIDS pandemic.
在当今发达国家,神经梅毒的临床诊断已极为罕见,尽管梅毒在工业化国家的少数地区以及大多数第三世界国家仍是一个重大的健康问题。这种明显的下降可能是由于在青霉素时代后,无症状神经梅毒的数量增加,以及病例表现为细微、不明确的综合征,而非典型的脊髓痨和麻痹性痴呆表现。本回顾性研究旨在报告在印度北部一家三级护理医院诊断出的神经梅毒病例,并分析这些病例的实验室和临床参数。
确定了在昌迪加尔医学教育与研究研究生院(PGIMER)13年期间(1990年1月至2002年12月)出现的疑似神经梅毒病例。神经梅毒的诊断基于临床表现、梅毒既往史、常规脑脊液生化检查(蛋白质和白细胞)以及血清学证据[血清和脑脊液性病研究实验室(VDRL)及梅毒螺旋体颗粒凝集试验(TPPA)]。
共确定了25例神经梅毒病例,18例(72%)脑脊液VDRL呈阳性,22例(88%)脑脊液蛋白质升高,24例(96%)脑脊液单核细胞增多。所有25例病例血清VDRL均呈阳性。3例患者无症状(2例一期梅毒;1例早期潜伏梅毒),8例为二期梅毒,14例为三期梅毒。2例神经梅毒病例HIV血清学也呈阳性。7例(28%)患者影像学检查异常。
在印度这样的国家,神经梅毒仍然是一个问题,尤其是在艾滋病大流行的时代,需要高度的怀疑指数和临床专业知识才能进行适当的诊断和妥善管理。